logging in or signing up kiran majumdar shaw ayushi.kumar95 Download Post to : URL : Related Presentations : Let's Connect Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Copy embed code: Embed: Flash iPad Dynamic Copy Does not support media & animations Automatically changes to Flash or non-Flash embed WordPress Embed Customize Embed URL: Copy Thumbnail: Copy The presentation is successfully added In Your Favorites. Views: 3927 Category: Education License: All Rights Reserved Like it (3) Dislike it (2) Added: February 14, 2011 This Presentation is Public Favorites: 4 Presentation Description No description available. Comments Posting comment... By: rameshmcombed (20 month(s) ago) Sir Pls Allow me to Download the PPT Saving..... Post Reply Close Saving..... Edit Comment Close By: parthaudi (29 month(s) ago) pls. grant me the permissions for downloading this ppt.......... Saving..... Post Reply Close Saving..... Edit Comment Close By: kotak27 (31 month(s) ago) pls. give me permission to download this ppt Saving..... Post Reply Close Saving..... Edit Comment Close By: sgkkr (35 month(s) ago) Please allow me to download the ppt presentation on Kiran Mazumdar Shaw Saving..... Post Reply Close Saving..... Edit Comment Close By: sgkkr (35 month(s) ago) Please allow me to download the ppt presentation on Kiran Mazumdar Shaw Saving..... Post Reply Close Saving..... Edit Comment Close loading.... See all Premium member Presentation Transcript Business Tycoon: Business Tycoon Kiran Mazumdar ShawMADE BY:: MADE BY : Ayushi Kumar Iti Verma Nishima Bhalla Shodhika GuptaAcknowledgement: Acknowledgement We would like to thank our teacher Mrs. Shalini who has given us this wonderful opportunity to make this presentation which has contributed a lot to our corporate knowledge. We have taken reference from internet (www.Google.com )BIOGRAPHY: BIOGRAPHYSlide 5: Kiran Mazumdar Shaw Born: March 23, 1953 Chairman & Managing Director of Biocon Ltd; India's biggest biotechnology company. In 2004, she became India's richest woman. Felicitated with Padmashri (1989) and Padma Bhushan (2005).Slide 6: Kiran Mazumdar Shaw was born on March 23, 1953 in Bangalore. She had her schooling at Bishop Cotton Girls School and Mount Carmel College at Bangalore. After doing completing her B.Sc. in Zoology from Bangalore University in 1973, she went to Ballarat University in Melbourne, Australia and qualified as a master brewer.Slide 7: Kiran Mazumdar Shaw started her professional career as trainee brewer in Carlton & United Beverages in 1974. In 1978, she joined as Trainee Manager with Biocon Biochemicals Limited in Ireland. In the funds for her business. Banks were hesitant to give loan to her as biotechnology was a totally new field at that point of time and she was a woman entrepreneur, which was a rare phenomenon. same year, Kiran Mazumdar Shaw founded Biocon India in collaboration with Biocon Biochemicals Limited, with a capital of Rs.10,000. She initially faced many problems regarding funds for her business. Banks were hesitant to give loan to her as biotechnology was a totally new field at that point of time and she was a woman entrepreneur, which was a rare phenomenon.Slide 8: Biocon's initial operation was to extract an enzyme from papaya. Under Kiran Mazumdar Shaw's stewardship Biocon transformed from an industrial enzymes company to an integrated biopharmaceutical company with strategic research initiatives. Today, Biocon is recognised as India's pioneering biotech enterprise.BIOCON INDIA: BIOCON INDIA . Biocon was founded on November 29, 1978 as a joint venture between Biocon Biochemicals Ltd. of Ireland and an Indian entrepreneur, Kiran Mazumdar Shaw. In 1979, Biocon became the first Indian company to manufacture and export enzymes to USA and Europe. Unilever plc. acquired Biocon Biochemicals Ltd. in Ireland in 1979 and merged it with its subsidiary, Quest International. In 1989, Biocon became the first Indian biotech company to receive US funding for proprietary technologies.Slide 10: Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases.They offer novel therapies on a platform of affordable innovation. They believe in strategic licensing partnerships which rapidly provide wider global access and greater market penetration. More significantly, they will enable to deliver breakthrough therapeutics to millions of patients the world over.Slide 11: Over the years, they have systematically leveraged their technology platforms from enzymes to small molecules to recombinant proteins and antibodies. Through partnerships and alliances, Biocon has strategically moved up the value chain from supplying pharmaceutical bulk activities to developing proprietary molecules and their own branded formulations.PRODUCTS AND SERVICES OFFERED BY BIOCON: PRODUCTS AND SERVICES OFFERED BY BIOCONBIOPHARMACEUTICALS: BIOPHARMACEUTICALS The Indian Pharmaceutical company biocon is capable to meet the country's demand for every drug. The manufaturing units within the country are meeting about 70% of the country's drug requirements. The drug production sector is equipped with technology and researched knowledge base. The company produces drugs worth rupees 18000 crores and is growing at 9 per cent every year. It offers quality products with internationally accepted quality standards. There are many production units in India with products sold at competitive lower prices than international drug prices.ENZYMES: ENZYMES Enzymes: Biocon is India's largest producer and exporter of enzymes. It manufactures and markets a broad range of industrial enzymes, food additives and process aids. Biocon is the first enzyme company globally to receive the ISO 9001 accreditation. Enzymes manufactured by Biocon are: Amylases, Cellulases , Catalase , Lipases, Glucanases , Phytases , Proteases, and Pectinases .CLINICAL RESEARCH: CLINICAL RESEARCH Clinical Research: Biocon subsidiary offers global biotechnology and pharmaceutical majors strong clinical trial services, regulatory and laboratory capabilities for clinical drug development. Its value added services include value-added services include patient registries and clinical databases in diabetes, lipidemia , oncology, cardiovascular diseases.CUSTOM RESEARCH: CUSTOM RESEARCH Biocon subsidiary conduct high value R&D in early stage drug discovery and development for a diverse global clientele.ACHIEVEMENTS: ACHIEVEMENTSSlide 20: Padmashri for pioneering biotechnology in India, Government of IndiPadmashri for pPadmashri for pioneering biotechnology in India, Government of Indiioneering biotechnology in India, Government of Indi Padmashri for pioneering biotechnology in India, Government of Indi Padmashri for pioneering biotechnology in India, Government of India Kiran Mazumdar Shaw is the recipient of several prestigious awards. These include ET Businesswoman of the Year, Best Woman Entrepreneur, Model Employer, Ernst & Young's Entrepreneur of the Year Award for Life Sciences & Healthcare, Leading Exporter, Outstanding Citizen, Technology Pioneer, etc. Government of India also felicitated her with Padmashri (1989) and Padma Bhushan (2005).CONCLUSION: CONCLUSIONSlide 22: The role of business Women in economic development is inevitable. Now-a-days women enter not only in selected professions but also in professions like trade, industry and engineering. Women are also willing to take up business and contribute to the Nation's growth. There role is also being recognized and steps are being taken to promote women entrepreneurship. Resurgence of entrepreneurship is the need of the hour. Women entrepreneurship must be moulded properly with entrepreneurial traits and skills to meet the changes in trends, challenges global markets and also be competent enough to sustain and strive for excellence in the entrepreneurial arena so that one day every indian woman sets an example as kiran did. You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.